Vitiligo surgical treatments are considered only in specific circumstances and usually after other treatment options have not been effective. These approaches are uncommon within routine NHS care and are typically offered through specialist or private services. Some treatments for vitiligo are not routinely available on the NHS. People may consider these options if conventional treatments have not worked. However, The Vitiligo Society cannot recommend using surgical or specialist treatments without strong clinical evidence, due to the limited number of high‑quality trials demonstrating long‑term effectiveness.

We strongly advise checking the qualifications, experience and regulatory status of any private practitioner before paying for surgical or specialist procedures.

Surgical treatments are generally only considered when:

These procedures are offered infrequently in the UK and usually only in specialist or private settings.

Skin grafting involves transferring a small section of healthy, pigmented skin to an area that has lost pigment. This procedure is generally used only when vitiligo affects small, localised areas.

Skin grafting is suitable only for people with very stable vitiligo, typically where no new patches have appeared and existing patches have not spread for at least two years.

This treatment is rarely used in the UK because of several disadvantages, including:

ReCell® is a newer procedure that involves taking a small sample of normal skin. The skin cells are separated and then sprayed onto areas affected by vitiligo to encourage repigmentation.

Although this approach is less invasive than traditional skin grafting, it still involves skin trauma, and repigmentation can take several months to develop. Further research is needed to establish how effective this treatment is in both the short and long term.

Bleaching is a permanent and non‑reversible treatment that results in total loss of skin colour. A hydroquinone‑based medicine is applied repeatedly to pigmented areas to lighten them so they match depigmented skin.

This process destroys pigment cells, meaning future repigmentation is not possible in treated areas. The NHS and the British Skin Association advise that bleaching should be considered only when:

Important considerations include:

Laser treatments are available only privately and can be costly. Evidence for their effectiveness in vitiligo is mixed.

Excimer laser therapy is used to treat localised vitiligo and delivers high‑energy light at a specific wavelength (308 nm). This approach can induce repigmentation over shorter periods and limits exposure to surrounding skin.

Laser treatment is often combined with topical therapies, such as calcineurin inhibitors or topical steroids, to enhance response.

Climatotherapy uses natural environmental factors to support treatment. For vitiligo, this often refers to treatment centres near the Dead Sea, where high mineral content, dry climate and lower UV exposure are thought to support repigmentation in some people.

Evidence for climatotherapy remains limited, and access usually requires travel and private funding.

Another treatment currently in clinical trials is VYN201, a gel designed to target specific immune pathways involved in vitiligo. Further research is required before its safety and effectiveness can be established.

Complementary treatments are widely advertised online, but there is no reliable evidence to support the safety or effectiveness of most alternative therapies for vitiligo. Research indicates that many alternative treatments are costly and ineffective. Ginkgo biloba is occasionally cited as a possible exception, but evidence remains limited.

You may also find these pages helpful:

You may also find the following NHS‑endorsed sources helpful when learning how vitiligo is diagnosed: NHS overview of vitiligo & British Association of Dermatologists guidance on vitiligo.